USPTO serial 79219570
BIOISMARKER
Reviewed by CopyMark Law Group
Reg. 5592414Status 709
- Filing date
- Status date
- Registration date
- Oct 30, 2018
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOISMARKER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kisuk Lee
Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Ave, Suite 400St. Louis, MO 63105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents for immunization disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; apparatus for use in medical analysis, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical genetic testing devices, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical genetic fragment analyzers; medical genetic analyzer; medical absorption analysis apparatus, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; DNA extraction and purification apparatus for medical purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; in vitro diagnostic devices, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments for DNA analysis, other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments for RNA analysis, other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments for protein analysis, other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; gene and genetic testing apparatus, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; cancer diagnosis apparatus, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; diagnostic apparatus for medical purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical body composition monitor; immunoassay apparatus for diagnostics, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; miniaturized sensors for use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 20, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 20, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jan 16, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 16, 2025 | C71T | CANCELLED SECTION 71 | — |
| Oct 30, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 30, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 11, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 25, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 3, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 13, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 19, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Dec 18, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 18, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 6, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 5, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 30, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |